// App-Quantinova.ai

[AB0534] : PODOCYTIC ABNORMALITIES IN SLE PARALLEL MECHANISM AFFECTING KIDNEY

Researchers

Presenter

  • M. Vankalakunti

Principal Investigators

  • V.K.R. Rao

  • B. Dharmanand

  • K. Babu

  • R. Bonu

  • S. Ballal

  • R. Bhat

  • V. Guptha

  • S. Rani

  • L. Umesh

  • S. Nalloor

  • J. Kiran

  • M. Bipin

  • S. Rampure

Medical Centers

  • Nephrology, Manipal Hospitals Bangalore, Bangalore, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Urology

Disease

  • Focal segmental glomerulosclerosis

  • End stage renal disease

  • Renal insufficiency

  • Nephrotic syndrome

  • Glomerulosclerosis

  • Glomerulonephritis

  • Lupus nephritis

  • Renal disease

  • Albuminuria

  • Nephritis

  • Lupus

Biomarkers

  • Alpha-Actinin 4

Drug/Treatment

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim